123 related articles for article (PubMed ID: 7756670)
41. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
[TBL] [Abstract][Full Text] [Related]
42. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
43. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.
Osada H; Grutz G; Axelson H; Forster A; Rabbitts TH
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9585-9. PubMed ID: 7568177
[TBL] [Abstract][Full Text] [Related]
44. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
45. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
[TBL] [Abstract][Full Text] [Related]
46. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein.
Prasad KS; Brandt SJ
J Biol Chem; 1997 Apr; 272(17):11457-62. PubMed ID: 9111058
[TBL] [Abstract][Full Text] [Related]
47. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
[TBL] [Abstract][Full Text] [Related]
48. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
Wadman IA; Hsu HL; Cobb MH; Baer R
Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
[TBL] [Abstract][Full Text] [Related]
49. TAL1 expression does not occur in the majority of T-ALL blasts.
Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
[TBL] [Abstract][Full Text] [Related]
50. Characterization of a basic helix-loop-helix protein, ABF-1: nuclear localization, transcriptional properties, and interaction with Id-2.
Wong J; Funes-Duran M; Ahlberg J; Round J; O'Connell R; Miller R; Chen E; Richmond PA; Vierra CA
DNA Cell Biol; 2001 Aug; 20(8):465-71. PubMed ID: 11560778
[TBL] [Abstract][Full Text] [Related]
51. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells.
Tang T; Arbiser JL; Brandt SJ
J Biol Chem; 2002 May; 277(21):18365-72. PubMed ID: 11904294
[TBL] [Abstract][Full Text] [Related]
52. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia.
François S; Delabesse E; Baranger L; Dautel M; Foussard C; Boasson M; Blanchet O; Bernard O; Macintyre EA; Ifrah N
Genes Chromosomes Cancer; 1998 Sep; 23(1):36-43. PubMed ID: 9713995
[TBL] [Abstract][Full Text] [Related]
53. The helix-loop-helix gene SCL: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development.
Robb L; Begley CG
Int J Biochem Cell Biol; 1996 Jun; 28(6):609-18. PubMed ID: 8673726
[TBL] [Abstract][Full Text] [Related]
54. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
Cheng JT; Hsu HL; Hwang LY; Baer R
Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
[TBL] [Abstract][Full Text] [Related]
55. Expression of TAL-1 proteins in human tissues.
Pulford K; Lecointe N; Leroy-Viard K; Jones M; Mathieu-Mahul D; Mason DY
Blood; 1995 Feb; 85(3):675-84. PubMed ID: 7833471
[TBL] [Abstract][Full Text] [Related]
56. SCL gene in human tumors.
Rockman S; Begley CG; Kannourakis G; Mann GJ; Dobrovic AN; Kefford RF; McGrath K
Leukemia; 1992 Jul; 6(7):623-5. PubMed ID: 1625484
[TBL] [Abstract][Full Text] [Related]
57. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.
Bernard O; Guglielmi P; Jonveaux P; Cherif D; Gisselbrecht S; Mauchauffe M; Berger R; Larsen CJ; Mathieu-Mahul D
Genes Chromosomes Cancer; 1990 Jan; 1(3):194-208. PubMed ID: 1964581
[TBL] [Abstract][Full Text] [Related]
58. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
Kallianpur AR; Jordan JE; Brandt SJ
Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
[TBL] [Abstract][Full Text] [Related]
59. Absence of SCL mutations in myeloid malignancies.
Delabesse E; Li J; Schnittger S; Hiddemann W; Green AR
Br J Haematol; 2003 Feb; 120(3):482-3. PubMed ID: 12580964
[TBL] [Abstract][Full Text] [Related]
60. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene.
Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; Viganò G; Biondi A
Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
